Designing a self-associated cationic polymer for enhanced compatibility, palatability, and gastric release of cefuroxime axetil

Biomacromolecules

Volumn 8, Issue 2, 2007, Pages 532-542

  Menjoge, Anupa R ^a   Kulkarni, Mohan G ^a  

^a NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADATION; DIFFERENTIAL SCANNING CALORIMETRY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHILICITY; HYDROPHOBICITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

CEFUROXIME AXETIL; GASTRIC RELEASE; PALATABILITY; SELF-ASSOCIATED CATIONIC POLYMER;

BIOPOLYMERS;

2 HYDROXYETHYL METHACRYLATE; 4 VINYLPYRIDINE; CEFUROXIME AXETIL; HYDROXYL GROUP; METHACRYLIC ACID METHYL ESTER; MONOMER; NITROGEN; POLYMER; PYRIDINE;

ARTICLE; BIOCOMPATIBILITY; BITTER TASTE; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG DEGRADATION; DRUG DOSAGE FORM; DRUG IMPURITY; DRUG RELEASE; DRUG SOLUBILITY; ENCAPSULATION; HEAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROGEN BOND; HYDROPHILICITY; HYDROPHOBICITY; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE; PH; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BIOCOMPATIBLE MATERIALS; CATIONS; CEFUROXIME; DRUG CARRIERS; DRUG DESIGN; HYDROGEN-ION CONCENTRATION; POLYMERS; STOMACH; TASTE;

EID: 33847326809     PISSN: 15257797     EISSN: None     Source Type: Journal    
DOI: 10.1021/bm060673v     Document Type: Article

References (63)

1. Langer, R.; Cima, L. G.; Tamada, J. A.; Wintermant, E. Biomaterials 1990, 11, 738-745.
2. Serajuddin, A. M.; Thakur, A. B.; Ghoshal, R. N.; Fakes, M. G.; Ranadive, S. A.; Morris, K. R.; Varia, S. A. J. Pharm. Sci. 1999, 88, 696-704.
3. Mura, P.; Bettinetti, G. P.; Faucci, M. T.; Manderioli, A.; Parrini, P. L. Thermochim. Acta 1998, 321, 59-65.
4. Novoa, G. A. G.; Ki, J. H.; Mirza, S.; Antikainen, O.; Colarte, A. I.; Paz, A. S.; Yliruusi, J. Eur. J. Pharm. Biopharm. 2005, 59, 343-350.
5. Verma, R. K.; Garg, S. J. Pharm. Biomed. Anal. 2005, 38, 633-644.
6. Wissing, S.; Craig, D. Q. M.; Barker, S. A.; Moore, W. D. Int. J. Pharm. 2000, 199, 141-150.
7. Ceschel, G. C.; Badiello, R.; Ronchi, C.; Maffei, P. J. Pharm. Biomed. Anal. 2003, 32, 1067-1072.
8. Mukherji, G.; Goel, S.; Arora, V. K. U. S. Patent 6,565,877, 2003.
9. Friend, D. J. Microencapsulation 1992, 9, 469-480.
10. Albertini, B.; Cavallari, C.; Passerini, N.; Voinovich, D.; Gonzalez-Rodriguez, M. L.; Magarotto, L.; Rodriguez, L. Eur. J. Pharm. Sci. 2004, 21, 295-303.
11. Robson, H.; Craig, D.; Deutsch, D. Int. J. Pharm. 1999, 190, 183-192.
12. Cuna, M.; Lorenzo-Lamosa, M.; Vila-Jato, J.; Torres, D.; Alonso, M. Drug Dev. Ind. Pharm. 1997, 23, 259-265.
13. Lorenzo-Lamosa, M.; Cuna, M.; Vila-Jato, J.; Torres, D.; Alonso, M. J. Microencapsulation 1997, 14, 607-616.
14. Donn, K.; James, N.; Powell, J. J. Pharm. Sci. 1994, 83, 842-844.
15. Dantzig, A. H.; Dale, C.; Duckworth, L.; Tabas, B. Biochim. Biophys. Acta 1994, 1191, 7-13.
16. Campbell, C.; Chantrell, L.; Eastmond, R. Biochem. Pharmacol. 1987, 36, 2317-2324.
17. Ruiz-Balaguer, N.; Nacher, A., Casabo, V.; Merino, M. Antimicrob. Agents Chemother. 1997, 41, 445-448.
18. In Physicians' Desk Reference; 56th Ed.; 2002, pp 1892-1902; Medica Economics Company Inc.: Montvale, New Jersey.
19. Finn, A.; Straughn, A.; Meyer, M.; Chubb, J. Biopharm. Drug Dispos. 1987, 8, 519-526.
20. Deutsch, D. S.; Anwar, J. U. S. Patent 4,897,270, 1990.
21. USP 26-NF 21; United States Pharmacopoeia: Rockville, MD, 2003.
22. Kulkarni, M. G.; Menjoge, A. R. U. S. Patent 20050137372 A1, 2005.
23. Kulkarni, M. G.; Menjoge, A. R. U. S. Patent 20050136114 A1, 2005.
24. Park, J.; Lim, Y.; Kwon, Y.; Jeong, B.; Choi, Y.; Kim, S. J. Polym. Sci., Part A: Polym. Chem. 1999, 37, 2305-2309.
25. Functional Monomers; Their Preparation, Polymerization, and Application; Yocum, R. H., Nyquist, E. B., Eds.; Marcel Dekker: New York, 1974; Vol. 2.
26. Tomme, S.; Steenbergen, M.; Smedt, S.; Nostrum, C.; Hennink, W. Biomaterials 2005, 26, 2129-2135.
27. Radeva, T.; Milkova, V.; Petkanchin, I. J. Colloid Interface Sci. 2004, 279, 351-356.
28. Pefferkorn, E.; Elaissari, A. J. Colloid Interface Sci. 1990, 138, 187-194.
29. Cesteros, L. C.; Meaurio, E.; Katime, I. Macromolecules 1993, 26, 2323-2330.
30. Wang, Y.; Robertson, J.; Spillman, W.; Claus, R. Pharm. Res. 2004, 21, 1362-1373.
31. Agarwala, R.; Unferb, S.; Mallapragadaa, K. J. Controlled Release 2005, 103, 245-258.
32. Mao, S.; Shua, X.; Unger, F.; Wittmar, M.; Xie, X.; Kissel, T. Biomaterials 2005, 26, 6343-6356.
33. Bruining, M.; Blaauwgeers, H.; Kuijer, R.; Pels, E.; Nuijts, R.; Koole, L. Biomaterials 2000, 21, 595-604.
34. Fischer, D.; Ahlemeyer, Y.; Krieglstein, J.; Kissel, T. Biomaterials 2003, 24, 1121-1131.
35. Said, A. Biomaterials 2005, 26, 2733-2739.
36. Prochazka, K.; Martin, T.; Munk, P.; Webber, S. Macromolecules 1996, 29, 6518-6525.
37. Qiu, Y.; Park, K. Adv. Drug Delivery Rev. 2001, 53, 321-339.
38. Crisp, H. A.; Clayton J. C. U. S. Patent 4,820,833, 1989.
39. Yoon, G.; Jeong, H. S.; Yim S. S. PCT Application WO 09843980A1, 1998.
40. Hwang, T. S.; Ahn, C. Y. PCT Application WO 00216372 A1, 2002.
41. Fabre, H.; Bork, H. I.; Lerner, D. A. J. Pharm. Sci. 1994, 83, 553-558.
42. Cesteros, L.; Velada, J.; Katime, L. Polymer 1995, 36, 3183-3189.
43. Ruokolainen, J.; Brinke, G.; Ikkala, O. Macromolecules 1996, 29, 3409-3415.
44. Yarapathi, R. V.; Reddy, S. M.; Tammishetti, S. React. Funct. Polym. 2005, 64, 157-161.
45. Goh, S. H.; Lee, S. Y.; Zhou, X.; Tan, K. L. Macromolecules 1998, 31, 4260-4264.
46. Nguyen, N. T. Pharm. Res. 1991, 81, 893-898.
47. Tejchman, B.; Jarominska, M.; Horodecka, M.; Oszczapowicz, I. Acta Pol. Pharm. 1995, 52, 477-482.
48. Tejchman, B., Oszczapowicz, I. Acta Pol. Pharm. 1997, 54, 7-12.
49. Zajac, M.; Jelinska, A.; Dobrowolski, L.; Oszczapowicz, I. J. Pharm. Biomed. Anal. 2003, 32, 1181-1187.
50. Zivanovic, L., Ivanovic, I., Vladimirov, S., Zecevic, M. J. Chromatogr., B: Biomed. Sci. Appl. 2004, 800, 175-179.
51. Woo, J. S.; Chang H. C. U. S. Patent 6,107,290, 2000.
52. Jo, G. H.; Yu, J. H.; Yun, J. H.; Hwang, S. J.; Woo, J. S. Preparation of amorphous form of cefuroxime axetil using supercritical fluid processing. In Controlled Release Society 29th Annual Meeting Proceedings, Seoul, South Korea, July 20-25, 2002; Abstract 057.
53. Woo, J. S.; Chang, H. C.; Lee, C. H. J. Korean Pharm. Sci. 2002, 32, 73-80.
54. Peyser, P. In Polymer Handbook, 3rd ed.; Brandup, J., Immergut, E. H., Eds.; Wiley: New York, 1989; pp 209-277.
55. Fried, J. R. Polymer Science and Technology; Prentice Hall: New Delhi, India, 1999; pp 132-164.
56. Schneider, H. A. Glass Transition (Theoretical Aspects). In Polymeric Materials Encyclopedia, CD-ROM version; Salamone J. C., Ed.; CRC Press: Boca Raton, FL, 1996.
57. Jiang, M., Li, M.; Xiang, M.; Zhou, H. Adv. Polym. Sci. 1999, 146, 121-196.
58. Mayo-Pedrosa, M.; Alvarez-Lorenzo, C.; Concheiro, A. J. Therm. Anal. Calorim. 2004, 77, 681-693.
59. Gebhart, C.; Kabanov, A. J. Controlled Release 2001, 73, 401-416.
60. Holgado, M. A.; Arevalo, M. A.; Fuentes, J. A.; Caraballo, I.; Llera, J. M.; Rabasco, A. M. Int. J. Pharm. 1995, 114, 13-21.
61. Okhamafe, A. O.; York, P. J. Pharm. Pharmacol. 1989, 41, 1-6.
62. Takka S. Farmaco 2003, 58, 1051-1056.
63. Handbook of Pharmaceutical Excipients, 3rd ed.; Kibbe, A. H., Ed.; American Pharmaceutical Association: Washington, DC, 2000.